Convalescent plasma reduces mortality by 10% in Covid-19 patients in acute respiratory distress and on artificial respiratory assistance
This is the conclusion of a multicentre study conducted by the University Hospital of Liège and ULiège in collaboration with 17 hospital intensive care departments in Belgium during the Covid-19 phases between October 2020 and March 2022.